$SESN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sesen Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sesen Bio, Inc.. Get notifications about new insider transactions in Sesen Bio, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
May 05 2021 | SESN | Sesen Bio, Inc. | Bourdow Carrie L. | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
May 05 2021 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
May 05 2021 | SESN | Sesen Bio, Inc. | Duker Jay S. | Director | Option Exercise | A | 2.79 | 92,500 | 258,075 | 92,500 | |
Feb 23 2021 | SESN | Sesen Bio, Inc. | Anderson Kirstin | Principal Accountin ... | Option Exercise | A | 3.17 | 50,000 | 158,500 | 50,000 | |
Feb 23 2021 | SESN | Sesen Bio, Inc. | MacDonald Glen C | Chief Technology Of ... | Option Exercise | A | 3.17 | 300,000 | 951,000 | 300,000 | |
Feb 23 2021 | SESN | Sesen Bio, Inc. | Forbes Monica | Chief Financial Off ... | Option Exercise | A | 3.17 | 580,000 | 1,838,600 | 580,000 | |
Feb 23 2021 | SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 3.17 | 2,000,000 | 6,340,000 | 2,000,000 | |
Feb 23 2021 | SESN | Sesen Bio, Inc. | Sullivan Mark | General Counsel & S ... | Option Exercise | A | 3.17 | 300,000 | 951,000 | 300,000 | |
May 08 2020 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
May 08 2020 | SESN | Sesen Bio, Inc. | Bourdow Carrie L. | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
May 08 2020 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
May 08 2020 | SESN | Sesen Bio, Inc. | Duker Jay S. | Director | Option Exercise | A | 0.63 | 59,000 | 37,135 | 59,000 | |
Feb 26 2020 | SESN | Sesen Bio, Inc. | Keyes Jason A | Director | Option Exercise | A | 0.82 | 118,000 | 97,043 | 118,000 | |
Feb 26 2020 | SESN | Sesen Bio, Inc. | Bourdow Carrie L. | Director | Option Exercise | A | 0.82 | 118,000 | 97,043 | 118,000 | |
Feb 18 2020 | SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 0.89 | 1,450,000 | 1,292,095 | 1,450,000 | |
Feb 18 2020 | SESN | Sesen Bio, Inc. | MacDonald Glen C | Chief Technology Of ... | Option Exercise | A | 0.89 | 275,000 | 245,053 | 275,000 | |
Feb 18 2020 | SESN | Sesen Bio, Inc. | Sullivan Mark | General Counsel & S ... | Option Exercise | A | 0.89 | 260,000 | 231,686 | 260,000 | |
Feb 18 2020 | SESN | Sesen Bio, Inc. | Anderson Kirstin | Principal Accountin ... | Option Exercise | A | 0.89 | 40,000 | 35,644 | 40,000 | |
Feb 18 2020 | SESN | Sesen Bio, Inc. | Anderson Kirstin | Principal Accountin ... | Option Exercise | A | 0.89 | 40,000 | 35,644 | 40,000 | |
Aug 28 2019 | SESN | Sesen Bio, Inc. | Forbes Monica | Chief Financial Off ... | Option Exercise | A | 1.13 | 280,000 | 316,400 | 280,000 | |
Aug 28 2019 | SESN | Sesen Bio, Inc. | Forbes Monica | Chief Financial Off ... | Option Exercise | A | 1.13 | 280,000 | 316,400 | 280,000 | |
Aug 05 2019 | SESN | Sesen Bio, Inc. | Sullivan Mark | General Counsel & S ... | Option Exercise | A | 1.16 | 200,000 | 232,000 | 200,000 | |
Jun 21 2019 | SESN | Sesen Bio, Inc. | Duker Jay S. | Director | Option Exercise | A | 1.48 | 52,500 | 77,700 | 52,500 | |
Jun 21 2019 | SESN | Sesen Bio, Inc. | DIXON WENDY L | Director | Option Exercise | A | 1.48 | 105,000 | 155,400 | 105,000 | |
Jun 21 2019 | SESN | Sesen Bio, Inc. | DAN LESLIE | Director | Option Exercise | A | 1.48 | 52,500 | 77,700 | 52,500 | |
Jun 21 2019 | SESN | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 1.48 | 52,500 | 77,700 | 52,500 | |
Jun 21 2019 | SESN | Sesen Bio, Inc. | LYNCH DANIEL | Director | Option Exercise | A | 1.48 | 52,500 | 77,700 | 52,500 | |
Feb 25 2019 | EBIO | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Option Exercise | A | 0.83 | 1,000,000 | 828,500 | 1,000,000 | |
Feb 25 2019 | EBIO | Sesen Bio, Inc. | Fitzgerald Richard F | Chief Financial Off ... | Option Exercise | A | 0.83 | 178,500 | 147,887 | 178,500 | |
Dec 06 2018 | EBIO | Sesen Bio, Inc. | Kim Dennis | Chief Medical Offic ... | Option Exercise | A | 1.70 | 425,000 | 722,500 | 425,000 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | LYNCH DANIEL | Director | Option Exercise | A | 2.24 | 52,500 | 117,600 | 52,500 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | HURLY STEPHEN A | President and CEO | Option Exercise | A | 1.59 | 87,150 | 138,569 | 272,580 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | DAN LESLIE | Director | Option Exercise | A | 2.24 | 52,500 | 117,600 | 52,500 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | Duker Jay S. | Director | Option Exercise | A | 2.24 | 52,500 | 117,600 | 52,500 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | CHANEY PAUL G | Director | Option Exercise | A | 2.24 | 52,500 | 117,600 | 52,500 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | Henderson Jane | Director | Option Exercise | A | 2.24 | 52,500 | 117,600 | 52,500 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | Celniker Abbie | Director | Option Exercise | A | 2.24 | 52,500 | 117,600 | 52,500 | |
Jun 14 2018 | EBIO | Sesen Bio, Inc. | DIXON WENDY L | Director | Option Exercise | A | 2.24 | 105,000 | 235,200 | 105,000 | |
Apr 11 2018 | EBIO | Eleven Biotherapeu ... | Fitzgerald Richard F | Chief Financial Off ... | Option Exercise | A | 1.50 | 200,000 | 300,000 | 200,000 | |
Apr 11 2018 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Option Exercise | A | 1.50 | 250,000 | 375,000 | 250,000 | |
Mar 16 2018 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Option Exercise | A | 1.59 | 105,000 | 166,950 | 105,000 | |
Jan 25 2018 | EBIO | Eleven Biotherapeu ... | Fitzgerald Richard F | Chief Financial Off ... | Option Exercise | A | 0.93 | 100,000 | 93,000 | 100,000 | |
Jan 22 2018 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Option Exercise | A | 1.59 | 80,430 | 127,884 | 80,430 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | LYNCH DANIEL | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | CHANEY PAUL G | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | DAN LESLIE | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | Duker Jay S. | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | Gertz Barry | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | Henderson Jane | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
May 23 2017 | EBIO | Eleven Biotherapeu ... | DIXON WENDY L | Director | Option Exercise | A | 1.48 | 8,072 | 11,947 | 8,072 | |
Apr 05 2017 | EBIO | Eleven Biotherapeu ... | DeCillis Arthur | Chief Medical Offic ... | Option Exercise | A | 2.28 | 19,246 | 43,881 | 19,246 | |
Apr 05 2017 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Option Exercise | A | 2.28 | 32,692 | 74,538 | 32,692 | |
Apr 05 2017 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 2.28 | 14,077 | 32,096 | 14,077 | |
Feb 16 2017 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Sell | S | 2.10 | 1,399 | 2,938 | 5,930 | 7.3 K to 5.9 K (-19.09 %) |
Sep 30 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | Director | Sell | S | 3.00 | 10,031 | 30,093 | 409,915 | 419.9 K to 409.9 K (-2.39 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 10,293 | 31,908 | 106,787 | 117.1 K to 106.8 K (-8.79 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 41,178 | 127,652 | 426,885 | 468.1 K to 426.9 K (-8.80 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 3,118 | 9,853 | 117,080 | 120.2 K to 117.1 K (-2.59 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 12,482 | 39,443 | 468,063 | 480.5 K to 468.1 K (-2.60 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.17 | 47,090 | 149,275 | 120,198 | 167.3 K to 120.2 K (-28.15 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.17 | 188,367 | 597,123 | 480,545 | 668.9 K to 480.5 K (-28.16 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.18 | 28,163 | 89,558 | 167,288 | 195.5 K to 167.3 K (-14.41 %) |
Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.18 | 112,731 | 358,485 | 668,912 | 781.6 K to 668.9 K (-14.42 %) |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | DAN LESLIE | Director | Option Exercise | A | 3.37 | 16,143 | 54,402 | 16,143 | |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | DAN LESLIE | Director | Grant | A | 0.00 | 3,582,328 | 0 | 3,582,328 | 0 to 3.6 M |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | DeCillis Arthur | Chief Medical Offic ... | Option Exercise | A | 3.37 | 100,000 | 337,000 | 100,000 | |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Option Exercise | A | 3.37 | 350,000 | 1,179,500 | 350,000 | |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | HURLY STEPHEN A | President and CEO | Grant | A | 0.00 | 398,031 | 0 | 398,031 | 0 to 398 K |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 3.37 | 100,000 | 337,000 | 100,000 | |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 0.28 | 6,664 | 1,866 | 20,000 | |
Sep 22 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | Director | Option Exercise | A | 0.28 | 29,988 | 8,397 | 90,000 | |
Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.75 | 64,509 | 241,909 | 195,451 | 260 K to 195.5 K (-24.81 %) |
Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.75 | 258,214 | 968,303 | 781,643 | 1 M to 781.6 K (-24.83 %) |
Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.39 | 10,778 | 36,537 | 259,960 | 270.7 K to 260 K (-3.98 %) |
Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.39 | 43,139 | 146,241 | 1,039,857 | 1.1 M to 1 M (-3.98 %) |
Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.31 | 1,939 | 6,418 | 270,738 | 272.7 K to 270.7 K (-0.71 %) |
Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.31 | 7,761 | 25,689 | 1,082,996 | 1.1 M to 1.1 M (-0.71 %) |
Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.16 | 536 | 2,230 | 272,677 | 273.2 K to 272.7 K (-0.20 %) |
Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.16 | 2,145 | 8,923 | 1,090,757 | 1.1 M to 1.1 M (-0.20 %) |
Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.18 | 8,802 | 36,792 | 273,213 | 282 K to 273.2 K (-3.12 %) |
Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.18 | 35,209 | 147,174 | 1,092,902 | 1.1 M to 1.1 M (-3.12 %) |
Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 8,145 | 36,734 | 282,015 | 290.2 K to 282 K (-2.81 %) |
Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 32,597 | 147,012 | 1,128,111 | 1.2 M to 1.1 M (-2.81 %) |
Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 52,985 | 238,962 | 1,833,802 | 1.9 M to 1.8 M (-2.81 %) |
Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 3,108 | 14,390 | 290,160 | 293.3 K to 290.2 K (-1.06 %) |
Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 12,441 | 57,602 | 1,160,708 | 1.2 M to 1.2 M (-1.06 %) |
Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 20,221 | 93,623 | 1,886,787 | 1.9 M to 1.9 M (-1.06 %) |
Aug 17 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Sell | S | 4.80 | 1,170 | 5,616 | 7,329 | 8.5 K to 7.3 K (-13.77 %) |
Jul 12 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 0.28 | 6,664 | 1,866 | 13,336 | |
Jul 12 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 13,328 | 3,732 | 26,672 | |
Jul 12 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Option Exercise | A | 0.28 | 29,988 | 8,397 | 60,012 | |
Jul 12 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 0.28 | 6,664 | 1,866 | 13,336 | |
Jul 12 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 13,328 | 3,732 | 26,672 | |
Jul 12 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Option Exercise | A | 0.28 | 29,988 | 8,397 | 60,012 | |
Jun 29 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Sell | S | 2.08 | 4,372 | 9,094 | 32,753 | 37.1 K to 32.8 K (-11.78 %) |
Jun 29 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Sell | S | 2.08 | 10,029 | 20,860 | 419,946 | 430 K to 419.9 K (-2.33 %) |
Jun 17 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 13,344 | 3,736 | 13,344 | |
Jun 17 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 0.28 | 6,672 | 1,868 | 6,672 | |
Jun 14 2016 | EBIO | Eleven Biotherapeu ... | Boxer Capital, LLC | 10% Owner | Sell | S | 2.74 | 177,140 | 486,090 | 297,860 | 475 K to 297.9 K (-37.29 %) |
Jun 14 2016 | EBIO | Eleven Biotherapeu ... | Boxer Capital, LLC | 10% Owner | Sell | S | 2.74 | 864,860 | 2,373,262 | 1,390,712 | 2.3 M to 1.4 M (-38.34 %) |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | LYNCH DANIEL | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | Gertz Barry | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | DIXON WENDY L | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | BERRY DAVID A | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | CHANEY PAUL G | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | Duker Jay S. | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | Henderson Jane | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Jun 10 2016 | EBIO | Eleven Biotherapeu ... | Pfeffer Cary | Director | Option Exercise | A | 1.83 | 8,072 | 14,772 | 8,072 | |
Feb 29 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 0.28 | 20,000 | 5,600 | 20,000 | |
Feb 29 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Chief Financial Off ... | Option Exercise | A | 0.28 | 28,313 | 7,928 | 28,313 | |
Feb 29 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 40,000 | 11,200 | 40,000 | |
Feb 29 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 60,400 | 16,912 | 60,400 | |
Feb 29 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Option Exercise | A | 0.28 | 90,000 | 25,200 | 90,000 | |
Feb 29 2016 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Option Exercise | A | 0.28 | 113,250 | 31,710 | 113,250 | |
Feb 17 2016 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Senior Vice Preside ... | Sell | S | 0.27 | 1,501 | 405 | 8,499 | 10 K to 8.5 K (-15.01 %) |
Dec 30 2015 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Sell | S | 2.85 | 4,427 | 12,617 | 32,973 | 37.4 K to 33 K (-11.84 %) |
Dec 30 2015 | EBIO | Eleven Biotherapeu ... | Furfine Eric Steven | Chief Scientific Of ... | Sell | S | 2.85 | 4,652 | 13,258 | 34,648 | 39.3 K to 34.6 K (-11.84 %) |
Dec 30 2015 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Sell | S | 2.85 | 10,155 | 28,942 | 429,975 | 440.1 K to 430 K (-2.31 %) |
Aug 14 2015 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Senior Vice Preside ... | Option Exercise | A | 4.09 | 20,000 | 81,800 | 20,000 | |
Aug 14 2015 | EBIO | Eleven Biotherapeu ... | MCCABE JOHN J | Senior Vice Preside ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 29 2015 | EBIO | Eleven Biotherapeu ... | Furfine Eric Steven | Chief Science Offic ... | Grant | A | 0.00 | 39,300 | 0 | 39,300 | 0 to 39.3 K |
Jun 29 2015 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Grant | A | 0.00 | 85,800 | 0 | 440,130 | 354.3 K to 440.1 K (+24.21 %) |
Jun 29 2015 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Grant | A | 0.00 | 37,400 | 0 | 37,400 | 0 to 37.4 K |
Jun 18 2015 | EBIO | Eleven Biotherapeu ... | Henderson Jane | Director | Option Exercise | A | 2.68 | 8,072 | 21,633 | 8,072 | |
Jun 18 2015 | EBIO | Eleven Biotherapeu ... | LYNCH DANIEL | Director | Option Exercise | A | 2.68 | 8,072 | 21,633 | 8,072 | |
Jun 18 2015 | EBIO | Eleven Biotherapeu ... | DIXON WENDY L | Director | Option Exercise | A | 2.68 | 8,072 | 21,633 | 8,072 | |
Jun 18 2015 | EBIO | Eleven Biotherapeu ... | CHANEY PAUL G | Director | Option Exercise | A | 2.68 | 8,072 | 21,633 | 8,072 | |
Jun 18 2015 | EBIO | Eleven Biotherapeu ... | Pfeffer Cary | Director | Option Exercise | A | 2.68 | 8,072 | 21,633 | 8,072 | |
Jun 18 2015 | EBIO | Eleven Biotherapeu ... | BERRY DAVID A | Director | Option Exercise | A | 2.68 | 8,072 | 21,633 | 8,072 | |
May 11 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 13.23 | 33,400 | 441,882 | 1,923,226 | 2 M to 1.9 M (-1.71 %) |
Feb 27 2015 | EBIO | Eleven Biotherapeu ... | PERRY GREGORY D | Chief Financial and ... | Option Exercise | A | 10.39 | 57,500 | 597,425 | 203,248 | |
Feb 27 2015 | EBIO | Eleven Biotherapeu ... | Celniker Abbie | President and CEO | Option Exercise | A | 10.39 | 145,000 | 1,506,550 | 282,795 | |
Feb 27 2015 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 10.39 | 65,000 | 675,350 | 150,827 | |
Feb 27 2015 | EBIO | Eleven Biotherapeu ... | Furfine Eric Steven | Chief Science Offic ... | Option Exercise | A | 10.39 | 52,500 | 545,475 | 217,854 | |
Feb 09 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.66 | 2,200 | 25,652 | 1,956,626 | 2 M to 2 M (-0.11 %) |
Feb 03 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.62 | 17,900 | 207,998 | 1,958,826 | 2 M to 2 M (-0.91 %) |
Jan 30 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.77 | 60,000 | 706,200 | 1,976,726 | 2 M to 2 M (-2.95 %) |
Jan 30 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.46 | 55,000 | 630,300 | 2,036,726 | 2.1 M to 2 M (-2.63 %) |
Jan 30 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.58 | 5,000 | 57,900 | 2,091,726 | 2.1 M to 2.1 M (-0.24 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.87 | 100 | 1,187 | 2,096,726 | 2.1 M to 2.1 M (0.00 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.82 | 100 | 1,182 | 2,096,826 | 2.1 M to 2.1 M (0.00 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.81 | 6 | 71 | 2,096,926 | 2.1 M to 2.1 M (0.00 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.88 | 494 | 5,869 | 2,096,932 | 2.1 M to 2.1 M (-0.02 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.77 | 100 | 1,177 | 2,097,426 | 2.1 M to 2.1 M (0.00 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.68 | 100 | 1,168 | 2,097,526 | 2.1 M to 2.1 M (0.00 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.53 | 200 | 2,306 | 2,097,626 | 2.1 M to 2.1 M (-0.01 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.50 | 200 | 2,300 | 2,097,826 | 2.1 M to 2.1 M (-0.01 %) |
Jan 26 2015 | EBIO | Eleven Biotherapeu ... | JAFCO Super V3 Investment Limi ... | 10% Owner | Sell | S | 11.90 | 3,664 | 43,602 | 2,098,026 | 2.1 M to 2.1 M (-0.17 %) |